Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice

Inflammation Research

Volumn 47, Issue 4, 1998, Pages 182-186

  Yamazaki, R ^a   Aiyama, R ^a   Matsuzaki, T ^a   Hashimoto, S ^a   Yokokura, T ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

5 Lipoxygenase; Diarylheptanoid; Ear edema; Leukotriene; YPE 01

Indexed keywords

1 (3,5 DIMETHOXY 4 HYDROXYPHENYL) 7 PHENYLHEPT 1 EN 3 ONE; 5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; HEPTANOIC ACID DERIVATIVE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; YPE 01;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; EDEMA; ENZYME IMMUNOASSAY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAST CELL LEUKEMIA; MOUSE; NONHUMAN; RAT; SKIN INFLAMMATION; STATISTICAL ANALYSIS;

EID: 0031941870     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050315     Document Type: Article

References (30)

1. Rouzer CA, Samuelsson B. On the nature of the 5-lipoxygenase reaction in human leukocytes: Enzyme purification and requirement for multiple stimulatory factors. Proc Natl Acad Sci USA 1985;82:6040-4.
2. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980;286:264-5.
3. Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-75.
4. Ford-Hutchinson AW. Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions. Springer Semin Immunopathol 1993;15:37-50.
5. Young RN, Gillard JW, Hutchinson JH, Léger S, Prasit P. Discovery of inhibitors of the 5-lipoxygenase activating protein (flap). J Lipid Med 1993;6:233-8.
6. Harris RR, Carter GW, Bell RL, Moore JL, Brooks DW. Clinical activity of leukotriene inhibitors. Int J Immunopharmacol 1995; 17:147-56.
7. Itokawa H, Aiyama R, Ikuta A. A pungent principle from Alpinia oxyphylla. Phytochemistry 1982;21:241-2.
8. Kiuchi F, Shibuya M, Sankawa U. Inhibitors of prostaglandin biosynthesis from Alpinia officinarum. Chem Pharm Bull 1982;30: 2279-82.
9. Flynn DL, Rafferty MF. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukotr Med 1986;22:357-60.
10. Iwakami S, Shibuya M, Tseng C-F, Hanaoka F, Sankawa U. Inhibition of arachidonate 5-lipoxygenase by phenolic compounds. Chem Pharm Bull 1986;34:3960-3.
11. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 1992;40:387-91.
12. Young JM, Wagner BM, Spires DA. Tachyphylaxis in 12-O-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema. J Invest Dermatol 1983;80:48-52.
13. Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985;17:197-204.
14. 4 synthesis by 5, 8, 11, 14-eicosatetraynoic acid in guinea pig polymorphonuclear leukocytes. J Biol Chem 1981;256:4156-9.
15. Jakschik BA, Kulczycki AJR, MacDonald HH, Parker CW. Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. J Immunol 1977;119:618-22.
16. Goetze AM, Fayer L, Bouska J, Bornemeier D, Carter GW. Purification of a mammalian 5-lipoxygenase from rat basophilic leukemia cells. Prostaglandins 1985;29:689-701.
17. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
18. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
19. Whittie BJR, Higgs GA, Eakins KE, Moncada S, Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980;284:271-3.
20. Hemler M, Lands WEM, Smith WL. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J Biol Chem 1976;251:5575-9.
21. Hammarström S, Falardeau P. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Prof Natl Acad Sci USA 1977;74:3691-5.
22. Wong WYL, Richards JS. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol Endocrinol 1991;5:1269-79.
23. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994;93:391-6.
24. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93:1095-101.
25. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, et al. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol Exp Ther 1994;270:1340-4.
26. Young JM, Spires DA, Bedord CJ, Wagner B, Ballaron SJ, De Young LM. The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol 1984;82:367-71.
27. Ishii K, Motoyoshi S, Kawata J, Nakagawa H, Takeyama K. A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice. Jpn J Pharmacol 1994;65:297-303.
28. Ruzicka T, Simmet T, Peskar BA, Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986;86:105-8.
29. 4 in atopic dermatitis: increased skin levels and altered sensitivity of peripheral blood T-cells. Allergy 1990;45:457-63.
30. Fauler J, Neumann CH, Tsikas D, Frölich JC. Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis. Br J Dermatol 1993;128:627-30.